单通路磷酸化抗体芯片

      从细胞膜、胞浆到细胞核，存在多条信号通路串联交叉形成的复杂信号网络。该信号网络在细胞受到胞外刺激后将信号通过级联放大、分散调节等方式传入胞内，引起一系列的综合性细胞应答。一种生物效应的出现往往存在多条信号通路的同步活化，可逆的磷酸化修饰反应则是细胞内部最为普遍和节能的信号蛋白活化调节方式。因此，找到激活的信号通路乃至发生磷酸化调变的通路蛋白，往往成生命科学研究的起点。

 

 

 

 

 

       信号通路磷酸化抗体芯片，采用三维高分子膜专用技术，在片基上高密度结合上百种高特异抗体，一次性可对特定经典信号通路上的信号蛋白进行全面筛选和系统分析。芯片针对每一个特定蛋白磷酸化位点，设置一对抗体分别检测其磷酸化（Phospho）和非磷酸化（non-Phospho）状态以提高磷酸化检测灵敏度和稳定性。由于信号蛋白会有多个重要磷酸化位点，这些磷酸化位点的功能各异。芯片设计时，针对同一个蛋白的不同磷酸化位点分别采用不同的配对抗体进行检测，尽可能做到全面、高效，是信号通路系统研究必不可少的工具。

|   抗体芯片特点

●  芯片规格为76 x 25 x 1 mm；

●  每种抗体设置6次技术重复；

●  适用于组织、细胞等多类型样本；

●  5 x10⁶细胞、100μg总蛋白量即可满足实验；

●  每个检测位点设有磷酸化和非磷酸化配对抗体；

●  可通用于人、小鼠、大鼠等多类型模式生物检测。

|   芯片产品列表（点击产品名称，下载抗体列表）

|   抗体芯片原理

|   服务资质

       上海威尼斯wns·8885556医药科技有限公司（威尼斯wns·8885556）推出的信号通路磷酸化抗体芯片产品，由美国Full Moon公司研发和生产。威尼斯wns·8885556技术团队与美国Full Moon公司自2009年开始即达成战略合作关系，在中国市场共同推广磷酸化抗体芯片技术。

       威尼斯wns·8885556秉持专业化的服务理念，着力打造中国专业蛋白芯片/抗体芯片服务的品牌标杆。威尼斯wns·8885556以高品质的数据质量为服务导向，在售前支持、样品管理、实验操作、数据分析、售后解答等各服务环节实行ISO9001质量管理体系一体化管理，确保科研合作者在获取高标准芯片数据的同时，也能收获优质的服务体验。

|   客户文献

[1]. Geng YJ, Chen SL, Yang Y, et al. Long-term exposure to genistein inhibits the proliferation of gallbladder cancer by downregulating the MCM complex. Science Bulletin, 2022(1). 2022 Apr il; 67(8): p. 813-824. IF=11.780

[2]. Du Changhong, Wang Xinmiao, Wu Yiding, et al. Renal Klotho and inorganic phosphate are extrinsic factors that antagonistically regulate hematopoietic stem cell maintenance. Cell Rep, 2022, 38: 110392.  IF=9.423

[3]. Fu Liwei, Li Pinxue, Zhu Junyao et al. Tetrahedral framework nucleic acids promote the biological functions and related mechanism of synovium-derived mesenchymal stem cells and show improved articular cartilage regeneration activity in situ. Bioact Mater, 2022, 9: 411-427.  IF=14.593

[4]. Jiang Wenhao, Jin Yunyun, Zhang Shiwei, et al. PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis. Bone Res, 2022, 10: 27.  IF=13.567

[5]. Bing Yao, Sha Zhu, Xiyi Wei, et al. The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression. Mol Cancer. 2022 May 27;21(1):119.  IF=27.401

[6]. Zhu Rongjia, Yan Tingdong, Feng Yingmei, et al. Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms. Cell Res, 2021, 31: 1244-1262.  IF=25.617

[7]. Lin Yao-Xin, Wang Yi, Ding Jianxun, et al. Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models. Sci Transl Med, 2021, 13: undefined.  IF=17.956

[8]. Li Hui, Jin Yuhong, Zhao Yu, et al. Targeted cell therapy for partial-thickness cartilage defects using membrane modified mesenchymal stem cells by transglutaminase 2. Biomaterials, 2021, 275: 120994.  IF=12.479

[9]. Long Hui, Yu Weina, Yu Sha, et al. Progesterone affects clinic oocyte yields by coordinating with follicle stimulating hormone via PI3K/AKT and MAPK pathways. J Adv Res, 2021, 33: 189-199.  IF=10.479

[10]. Huang Tinglei, Chen Biying, Wang Feng, et al. Rab1A promotes IL-4R/JAK1/STAT6-dependent metastasis and determines JAK1 inhibitor sensitivity in non-small cell lung cancer. Cancer Lett, 2021, 523: 182-194.  IF=8.679

[11]. Zhao Qun, Guo Jian, Wang Guizhen, et al. CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling. Cancer Lett, 2021, 511: 1-14.  IF=8.679

[12]. He D, Wu HG, Xiang JN, et al. Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway. Nat Commun. 2020 Jan 2;11(1):37.   IF=14.919

[13]. Chen WL, Jin X,Wang MS, et al. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling. JCI Insight. 2020 Feb 13;5(3):e131596.   IF=8.315

[14]. Yan LX, Li HY, Xia WL. Bioglass could increase cell membrane fluidity with ion products to develop its bioactivity. Cell Prolif. 2020 Nov;53(11):e12906.   IF=6.831

[15]. He D, Wu HG, Xiang JN, et al. Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway. Nat Commun. 2020 Jan 2;11(1):37.   IF=14.919

[16]. Zeng Q, Liu YM, Liu J, et al. Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells. Cell Death Dis. 2019 Aug 5;10(8):588.  IF=8.469

[17]. Yin LM, Xu YD, Peng LL, et al. Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance. Sci Transl Med. 2018 Feb 7;10(427):eaam8604.   IF=17.956

[18]. Gao YY, Bai XF, Zhang DJ , et al. Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis. Nat Struct Mol Biol. 2016 May;23(5):441-9.   IF=15.369

[19]. Jiang HL, Sun HF, Gao SP, et al. SSRP1 uppresses TGF-β-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling, Cancer Res. 2016 Feb 15;76(4):952-64.   IF=12.701

[20]. Kuang XY, Jiang HS, Li K, et al. The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis. Cancer Lett. 2016 Jul 10;377(1):87-96.   IF=8.679

[21]. Jia DS, Jing Y, Zhang ZF, et al. Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma. Cell Res. 2014 Feb;24(2):204  IF=25.617